• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Model Number VXAK0003
Medical Device Problem Code Failure to Advance (2524)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Pericardial Effusion (3271)
Date of Event 01/21/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported a pericardial effusion occurred and the procedure was cancelled.It was reported that versacross connect laac access solution was selected for watchman left atrial appendage closure procedure.During the procedure, when attempt was made for transseptal using versacross rf wire, it failed to cross, and no bubbles were noted in left atrium (la).So, a second attempt was made to cross, and bubbles were seen, however, the versacross rf wire did not cross.A third attempt was made and same issue noted.The physician tried different positioning on septum by putting more bend on versacross dilator.Transesophageal echocardiogram (tee) was checked, and a pericardial effusion was noted around right ventricle.Patient blood pressure was dropped when pe had occurred.A pericardiocentesis was performed due to hemodynamic compromise and 360 cc dark red blood was removed.The patient was admitted to hospital beyond standard of care and expected to fully recover.The device is not expected to be returned for analysis (disposed).It was confirmed that heparin was given just prior to transseptal puncture.No versacross device malfunctions were reported.It was noted a difficult visual windows due to heart rotated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICALE CIE INC
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
angela hinkley
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key21349842
Report Number2124215-2025-07160
Device Sequence Number7740972
Product Code DXF
UDI-Device Identifier00685447018346
UDI-Public00685447018346
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K150709
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberVXAK0003
Device Catalogue NumberVXAK0003
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/21/2025
Initial Report FDA Received Date02/10/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Life Threatening; Hospitalization;
Patient SexMale
Patient RaceWhite
-
-